Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial
在哥斯达黎加开展的PRIMAVERA研究（一项非随机、开放标签、免疫桥接、非劣效性试验）中，比较了9-14岁女孩接种单剂二价HPV疫苗后人乳头瘤病毒（HPV）16型和18型抗体浓度与18-25岁女性接种三剂四价HPV疫苗后HPV抗体浓度的变化：
期刊:Lancet Infectious Diseases
影响因子:
doi:10.1016/S1473-3099(25)00284-1
Cortés, Bernal; Ocampo, Rebeca; Porras, Carolina; Liu, Danping; Gail, Mitchell H; Sierra, Monica S; Herrero, Rolando; Lowy, Douglas R; Carvajal, Loretto J; Kemp, Troy J; Fantin, Romain; Schussler, John; Hildesheim, Allan; Sampson, Joshua N; Pinto, Ligia A; Schiller, John T; Kreimer, Aimée R
